Skip to content
Clinical Trials – home

Evangelisches Krankenhaus Hagen-Haspe gGmbH

Research site

Germany Brusebrinkstrasse 20, Haspe, 58135 Hagen, Germany

  • 1 trial recruiting
  • Atrial fibrillation · Cardiac failure · Thrombosis prophylaxis
  • Adult patients

About Specializations

Evangelisches Krankenhaus Hagen-Haspe gGmbH in Hagen, Germany specialises in clinical trials of conditions such as Atrial fibrillation, Cardiac failure, Thrombosis prophylaxis, Cerebrovascular accident prophylaxis, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases at Evangelisches Krankenhaus Hagen-Haspe gGmbH

Clinical research at this site focuses on cardiovascular diseases, with studies centered on heart failure and atrial fibrillation in the setting of acute coronary events. The trials aim to improve treatment effectiveness and reduce major complications in patients with complex heart and circulation conditions.

  • Evaluating a new treatment approach for chronic heart failure in patients who also have impaired kidney function, with the goal of lowering cardiovascular death and heart failure events.
  • Studying intensified antiplatelet treatment in people with atrial fibrillation and myocardial infarction undergoing coronary intervention, to better balance protection against ischemic events and bleeding risk.

The research program at the Klinik für Kardiologie und Rhythmologie reflects a strong interest in therapies that support patients with advanced cardiac disease and overlapping conditions such as kidney impairment and acute coronary syndrome.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Brusebrinkstrasse 20, Haspe58135 HagenGermany
Recruiting now
1 trial
Conditions studied
5

More sites in HagenGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Cardiac failure

Recruiting

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Myocardial infarction

Not recruiting

Study on Prasugrel or Ticagrelor for Patients with Atrial Fibrillation and Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Klinikum der Universitaet Muenchen AöR
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.